X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-10-14 | MU | Micron Technology Inc | Ray Michael Charles | SVP, GC | S - Sale | $947.29 | -40 | 56,248 | 0% | -$37,892 | ||||||
| D | 2026-10-14 | MU | Micron Technology Inc | Ray Michael Charles | SVP, GC | S - Sale+OE | $929.64 | -6,288 | 56,288 | -10% | -$5,845,568 | |||||
| DM | 2026-10-13 | BRCC | Brc Inc. | Hafer Evan | Founder, 10% | S - Sale+OE | $10.62 | -15,704 | 2,806,533 | -1% | -$166,730 | |||||
2026-10-13 | AAPL | Apple Inc. | Newstead Jennifer | SVP, GC, Government Affairs | S - Sale | $345.00 | -2,399 | 37,194 | -6% | -$827,655 | ||||||
| D | 2026-10-15 | ORKA | Oruka Therapeutics, Inc. | Goncalves Joana | Chief Medical Officer | S - Sale+OE | $74.81 | -7,000 | 31,771 | -18% | -$523,648 | |||||
2026-10-14 | IMSR | Terrestrial Energy Inc. /De/ | Pardee Charles G | Dir | P - Purchase | $2.95 | +7,500 | 14,258 | +111% | +$22,125 | ||||||
| D | 2026-10-14 | CRSP | Crispr Therapeutics AG | Kasinger James R. | GC, Secretary | S - Sale+OE | $49.26 | -1,040 | 95,857 | -1% | -$51,230 | |||||
| D | 2026-10-14 | CRSP | Crispr Therapeutics AG | Kulkarni Samarth | CEO | S - Sale+OE | $49.26 | -4,098 | 259,736 | -2% | -$201,867 | |||||
| D | 2026-10-13 | ONC | Beone Medicines Ltd. | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale+OE | $350.99 | -31,027 | 9,566,326 | 0% | -$10,890,074 | |||||
| D | 2026-10-15 | NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $25.00 | -1,452 | 117,227 | -1% | -$36,300 | |||||
2026-10-13 | P | Everpure, Inc. | Singh Ajay | Chief Product Officer | S - Sale | $155.24 | -18,267 | 270,095 | -6% | -$2,835,769 | ||||||
| M | 2026-10-13 | INM | Inmed Pharmaceuticals Inc. | Adar1 Capital Management, LLC | 10% | P - Purchase | $1.33 | +9,569 | 955,493 | +1% | +$12,719 | |||||
| D | 2026-10-14 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $539.99 | -9,500 | 668,728 | -1% | -$5,129,873 | |||||
| D | 2026-10-13 | TRXB | Trex Bio, Inc. | Alexandria Venture Investments, LLC | 10% | P - Purchase | $14.00 | +178,571 | 1,346,501 | +15% | +$2,499,994 | |||||
2026-10-13 | LWAY | Lifeway Foods, Inc. | Smolyansky Edward | 10% | S - Sale | $22.64 | -30,000 | 2,367,435 | -1% | -$679,200 | ||||||
| A | 2026-09-11 | MYO | Myomo, Inc. | Kovelman Harry | Chief Medical Officer | S - Sale | $1.27 | -15,844 | 89,889 | -15% | -$20,136 | |||||
| M | 2026-10-13 | PRTA | Prothena Corp Public Ltd Co | Scully William P | 10% | P - Purchase | $8.36 | +110,000 | 1,753,000 | +7% | +$920,049 | |||||
2026-10-13 | AMKR | Amkor Technology, Inc. | Faust Megan | CFO | S - Sale | $46.92 | -1,000 | 133,105 | -1% | -$46,920 | ||||||
| D | 2026-10-14 | REGN | Regeneron Pharmaceuticals, Inc. | Murphy Andrew J | Co-Chief Scientific Officer | S - Sale+OE | $772.70 | -4,147 | 52,247 | -7% | -$3,204,376 | |||||
2026-10-13 | BIOF | Blue Biofuels, Inc. | Kneppers Chris J | Dir | S - Sale | $0.10 | -100,000 | 19,872,677 | -1% | -$10,000 | ||||||
2026-10-15 | QTEX | Qtrex Quantum Ltd. | Parnes Tal | Dir | P - Purchase | $1.50 | +6,666 | 766,666 | +1% | +$9,999 | ||||||
2026-09-30 | NEOV | Neovolta Inc. | Hass John A | Dir | P - Purchase | $2.61 | +25,000 | 126,190 | +25% | +$65,250 | ||||||
2026-10-13 | VLN | Valens Semiconductor Ltd. | Lichtman Moshe | Dir | S - Sale | $1.64 | -3,750 | 118,950 | -3% | -$6,150 | ||||||
| M | 2026-10-01 | VLN | Valens Semiconductor Ltd. | Yaacobi Tal | Dir | S - Sale | $1.71 | -5,150 | 63,348 | -8% | -$8,796 | |||||
2026-10-12 | CUE | Cue Biopharma, Inc. | Ray Sumita | Chief Legal Compliance Officer | S - Sale | $28.05 | -1,844 | 116,701 | -2% | -$51,724 | ||||||
2026-10-12 | CUE | Cue Biopharma, Inc. | Meluzio Michael Vincent | VP, Prin. Accounting Officer | S - Sale | $28.05 | -1,144 | 47,817 | -2% | -$32,089 | ||||||
2026-10-12 | CUE | Cue Biopharma, Inc. | Lin Shao-Lee | CEO | S - Sale | $27.55 | -11,087 | 694,908 | -2% | -$305,490 | ||||||
| M | 2026-10-12 | BETA | Beta Technologies, Inc. | Clark Kyle | SEE REMARKS | S - Sale | $18.67 | -30,000 | 7,499,504 | 0% | -$560,177 | |||||
2026-10-14 | ZONE | Zone Frontier Inc. | Hassen Tyler Lewis | CEO | P - Purchase | $0.11 | +750,000 | 4,000,000 | +23% | +$85,200 | ||||||
2026-10-14 | FORM | Formfactor Inc | Slessor Mike | CEO | S - Sale | $125.20 | -11,098 | 455,596 | -2% | -$1,389,437 | ||||||
| M | 2026-10-12 | PVLA | Palvella Therapeutics, Inc. | Jenkins George M | Dir | S - Sale | $130.16 | -27,500 | 146,132 | -16% | -$3,579,476 | |||||
2026-10-14 | INBX | Inhibrx Biosciences, Inc. | Lappe Mark | CEO | P - Purchase | $84.56 | +10,040 | 970,453 | +1% | +$848,977 | ||||||
2026-10-12 | ELF | E.L.F. Beauty, Inc. | Franks Joshua Allen | SVP, Operations | S - Sale | $110.01 | -8,366 | 126,931 | -6% | -$920,310 | ||||||
2026-10-12 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $49.57 | -38,900 | 283,014 | -12% | -$1,928,195 | ||||||
| M | 2026-10-12 | P | Everpure, Inc. | Colgrove John | Chief Visionary Officer | S - Sale | $154.26 | -200,000 | 8,376,003 | -2% | -$30,852,839 | |||||
2026-10-12 | P | Everpure, Inc. | Giancarlo Charles H | CEO | S - Sale | $153.73 | -70,000 | 2,171,149 | -3% | -$10,761,314 | ||||||
2026-10-06 | QTTB | Q32 Bio Inc. | Morrison Jodie Pope | CEO | S - Sale | $8.32 | -3,221 | 340,038 | -1% | -$26,798 | ||||||
2026-10-06 | QTTB | Q32 Bio Inc. | Kalowski Lee | CFO, Pres | S - Sale | $8.32 | -1,301 | 137,170 | -1% | -$10,824 | ||||||
2026-10-06 | QTTB | Q32 Bio Inc. | Violette Shelia M. | Chief Scientific Officer | S - Sale | $8.32 | -917 | 163,131 | -1% | -$7,629 | ||||||
| DM | 2026-10-12 | HSY | Hershey Co | Hershey Trust Co Trustee In Trust For Milton Hershey School | 10% | S - Sale+OE | $163.31 | -30,000 | 625,749 | -5% | -$4,899,327 | |||||
2026-10-12 | CDXS | Codexis, Inc. | Erbez Georgia | See Remarks | S - Sale | $1.36 | -6,335 | 60,475 | -9% | -$8,619 | ||||||
2026-10-12 | CDXS | Codexis, Inc. | Moore Alison | Pres, CEO | S - Sale | $1.36 | -6,335 | 244,171 | -3% | -$8,619 | ||||||
2026-10-12 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $20.05 | -38,006 | 747,385 | -5% | -$762,013 | ||||||
| D | 2026-10-09 | DELL | Dell Technologies Inc. | Silver Lake Technology Investors V, L.P. | Dir, 10% | S - Sale+OE | $582.31 | -450 | 1,792,789 | 0% | -$262,040 | |||||
| D | 2026-10-13 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $545.52 | -9,500 | 668,728 | -1% | -$5,182,414 | |||||
| D | 2026-10-09 | DELL | Dell Technologies Inc. | Silver Lake Partners V De (Aiv), L.P. | Dir, 10% | S - Sale+OE | $582.31 | -25,494 | 1,792,789 | -1% | -$14,845,272 | |||||
| D | 2026-10-09 | DELL | Dell Technologies Inc. | Sl Spv-2, L.P. | Dir, 10% | S - Sale+OE | $582.30 | -44,408 | 1,792,789 | -2% | -$25,858,975 | |||||
| D | 2026-10-09 | DELL | Dell Technologies Inc. | Silver Lake Partners Iv, L.P. | Dir, 10% | S - Sale+OE | $582.45 | -50,454 | 1,792,789 | -3% | -$29,386,956 | |||||
2026-10-12 | NTAP | Netapp, Inc. | O'Callahan Elizabeth M | EVP, Chief Admin. Officer | S - Sale | $237.42 | -1,000 | 29,737 | -3% | -$237,420 | ||||||
| D | 2026-10-09 | DELL | Dell Technologies Inc. | Silver Lake Technology Investors Iv, L.P. | Dir, 10% | S - Sale+OE | $582.30 | -996 | 1,792,789 | 0% | -$579,972 | |||||
2026-10-12 | CRDO | Credo Technology Group Holding Ltd | Sutardja, Pantas | Dir | S - Sale | $212.22 | -1,540 | 5,891,716 | 0% | -$326,819 | ||||||
| M | 2026-10-12 | CRDO | Credo Technology Group Holding Ltd | Cheng Chi Fung | CTO | S - Sale | $194.07 | -31,290 | 5,737,715 | -1% | -$6,072,308 | |||||
| D | 2026-10-13 | JOBY | Joby Aviation, Inc. | Dehoff Kate | See Remarks | S - Sale+OE | $5.09 | -8,279 | 196,964 | -4% | -$42,140 | |||||
| D | 2026-10-13 | JOBY | Joby Aviation, Inc. | Allison Eric | Chief Product Officer | S - Sale+OE | $5.09 | -27,593 | 745,120 | -4% | -$140,448 | |||||
2026-10-13 | PL | Planet Labs Pbc | Raymond John W | Dir | S - Sale | $15.23 | -6,494 | 37,099 | -15% | -$98,893 | ||||||
| D | 2026-10-14 | NRIX | Nurix Therapeutics, Inc. | Gregory Julia P | Dir | S - Sale+OE | $23.40 | -22,583 | 10,750 | -68% | -$528,528 | |||||
| AM | 2024-10-28 | BIOE | Bio Essence Corp | Yan Yin | CEO, 10% | S - Sale | $1.50 | -287,845 | 13,396,000 | -2% | -$432,044 | |||||
2026-10-12 | ALMU | Aeluma, Inc. | Klamkin Jonathan | CEO | S - Sale | $10.53 | -100,000 | 1,169,297 | -8% | -$1,053,430 | ||||||
2026-10-12 | AAOI | Applied Optoelectronics, Inc. | Murry Stefan J. | CFO | S - Sale | $102.87 | -4,000 | 363,168 | -1% | -$411,480 | ||||||
2026-10-14 | NDSN | Nordson Corp | Morris Milton Mayo | Dir | S - Sale | $327.20 | -255 | 2,265 | -10% | -$83,436 | ||||||
| D | 2026-10-12 | INKT | Mink Therapeutics, Inc. | Buell Jennifer | CEO | S - Sale+OE | $10.56 | -6,938 | 74,195 | -9% | -$73,265 | |||||
2026-10-13 | XAIR | Beyond Air, Inc. | Lin Yi-Chien | 10% | P - Purchase | $2.21 | +2,607 | 148,000 | +2% | +$5,761 | ||||||
2026-10-12 | GEF | Greif, Inc | Bergwall Timothy | SVP, Chief Commercial Officer | S - Sale | $81.82 | -2,000 | 53,156 | -4% | -$163,640 | ||||||
2026-10-13 | IMSR | Terrestrial Energy Inc. /De/ | Irish Simon | CEO | P - Purchase | $3.01 | +16,900 | 5,183,609 | 0% | +$50,818 | ||||||
2026-10-12 | ASX | Ase Technology Holding Co., Ltd. | Uang Du-Tsuen | Chief Administration Officer | S - Sale | $752.00 | -3,000 | 838,000 | 0% | -$2,256,000 | ||||||
2026-10-09 | OCGN | Ocugen, Inc. | Musunuri Shankar | CEO | S - Sale | $0.95 | -525,991 | 5,049,241 | -9% | -$499,691 | ||||||
2026-10-13 | ANIP | Ani Pharmaceuticals Inc | Cook Meredith | SVP, GC, SEC. | S - Sale | $73.59 | -500 | 73,424 | -1% | -$36,795 | ||||||
2026-10-13 | ZONE | Zone Frontier Inc. | Hassen Tyler Lewis | CEO | P - Purchase | $0.12 | +1,250,000 | 3,250,000 | +63% | +$146,075 | ||||||
2026-10-08 | MOBX | Mobix Labs, Inc | Sansone Philip | CEO | S - Sale | $1.12 | -2,614 | 163,516 | -2% | -$2,934 | ||||||
| D | 2026-10-12 | LQDA | Liquidia Corp | Schundler Russell | GC | S - Sale+OE | $28.48 | -13,692 | 617,341 | -2% | -$389,948 | |||||
| D | 2026-10-12 | LQDA | Liquidia Corp | Saggar Rajeev | Chief Medical Officer | S - Sale+OE | $28.48 | -9,218 | 141,467 | -6% | -$262,529 | |||||
| D | 2026-10-12 | LQDA | Liquidia Corp | Moomaw Scott | Chief Commercial Officer | S - Sale+OE | $28.48 | -8,863 | 181,487 | -5% | -$252,418 | |||||
| D | 2026-10-12 | LQDA | Liquidia Corp | Krepp Sarah | Chief Human Resource Officer | S - Sale+OE | $28.48 | -5,245 | 115,241 | -4% | -$149,378 | |||||
2026-10-12 | LQDA | Liquidia Corp | Khindri Sanjeev | Chief Development Officer | S - Sale | $28.48 | -1,101 | 64,846 | -2% | -$31,356 | ||||||
| D | 2026-10-12 | LQDA | Liquidia Corp | Kaseta Michael | CFO, COO | S - Sale+OE | $28.48 | -18,938 | 340,148 | -5% | -$539,354 | |||||
| D | 2026-10-12 | LQDA | Liquidia Corp | Jeffs Roger | CEO | S - Sale+OE | $28.48 | -32,744 | 2,214,110 | -1% | -$932,549 | |||||
| D | 2026-10-12 | LQDA | Liquidia Corp | Boyle Dana | Chief Accounting Officer | S - Sale+OE | $28.48 | -5,892 | 165,609 | -3% | -$167,804 | |||||
| D | 2026-10-12 | LQDA | Liquidia Corp | Adair Jason | Chief Business Officer | S - Sale+OE | $28.48 | -7,301 | 177,957 | -4% | -$207,932 | |||||
| M | 2026-10-08 | ANET | Arista Networks, Inc. | Ullal Jayshree | CEO, Chairperson | S - Sale | $217.09 | -158,543 | 25,041,806 | -1% | -$34,417,690 | |||||
| DM | 2026-10-09 | ADPT | Adaptive Biotechnologies Corp | Rubinstein Julie | Pres, COO | S - Sale+OE | $25.81 | -35,643 | 377,802 | -9% | -$919,870 | |||||
| D | 2026-10-13 | RTSN | Retension Pharmaceuticals, Inc. | Keller Eric L. | CEO | P - Purchase | $12.00 | +20,800 | 464,407 | +5% | +$249,600 | |||||
| D | 2026-10-13 | RTSN | Retension Pharmaceuticals, Inc. | Berger Franklin M | Dir | P - Purchase | $12.00 | +10,000 | 22,517 | +80% | +$120,000 | |||||
| M | 2026-10-08 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $2.03 | +14,632 | 2,873,289 | +1% | +$29,683 | |||||
| D | 2026-10-09 | PTCT | Ptc Therapeutics, Inc. | Boulding Mark Elliott | EVP, CLO | S - Sale+OE | $64.26 | -192 | 105,272 | 0% | -$12,338 | |||||
2026-10-12 | LYEL | Lyell Immunopharma, Inc. | Aguirre Jarrad Mattieu | Chief Medical Officer | S - Sale | $8.63 | -422 | 19,857 | -2% | -$3,642 | ||||||
2026-10-09 | P | Everpure, Inc. | Chu Mona | Chief Accounting Officer | S - Sale | $151.40 | -5,112 | 125,982 | -4% | -$773,957 | ||||||
2026-10-08 | OCUL | Ocular Therapeutix, Inc | Anderman Todd | GC | S - Sale | $7.29 | -11,984 | 140,484 | -8% | -$87,363 | ||||||
2026-10-08 | P | Everpure, Inc. | Brown Andrew William Fraser | Dir | S - Sale | $156.03 | -4,268 | 24,915 | -15% | -$665,936 | ||||||
2026-10-08 | PBF | Pbf Energy Inc. | Control Empresarial De Capitales S.A. De C.V. | Add'l Rep. Persons-see Ex.99-1, 10% | S - Sale | $88.03 | -170,000 | 13,326,127 | -1% | -$14,965,434 | ||||||
| D | 2026-10-12 | ORKA | Oruka Therapeutics, Inc. | Agarwal Arjun | SVP, Finance | S - Sale+OE | $80.60 | -9,999 | 14,219 | -41% | -$805,889 | |||||
| D | 2026-10-12 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $550.70 | -9,500 | 668,728 | -1% | -$5,231,666 | |||||
| D | 2026-10-09 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $544.94 | -9,500 | 668,728 | -1% | -$5,176,936 | |||||
| D | 2026-10-08 | TRXB | Trex Bio, Inc. | Svlsf Vi, LLC | 10% | P - Purchase | $14.00 | +92,857 | 3,011,818 | +3% | +$1,299,998 | |||||
| D | 2026-10-12 | ZVRA | Zevra Therapeutics, Inc. | McFarlane Neil F. | Pres, CEO | S - Sale+OE | $11.25 | -20,000 | 417,225 | -5% | -$224,948 | |||||
| D | 2026-10-09 | KRNT | Kornit Digital Ltd. | Gazit Daniel | Chief Product Officer | S - Sale+OE | $19.01 | -552 | 32,217 | -2% | -$10,494 | |||||
2026-10-09 | TWST | Twist Bioscience Corp | Laponis Adam | CFO | S - Sale | $156.31 | -2,462 | 98,114 | -2% | -$384,823 | ||||||
2026-10-08 | CRDO | Credo Technology Group Holding Ltd | Fleming Daniel W. | CFO | S - Sale | $212.91 | -7,580 | 492,208 | -2% | -$1,613,831 | ||||||
| D | 2026-10-12 | CYTK | Cytokinetics Inc | Blum Robert I | Pres, CEO | S - Sale+OE | $62.88 | -7,500 | 282,710 | -3% | -$471,600 | |||||
2026-10-08 | HEI | Heico Corp | Mendelson Victor H | Co-COB, Co-CEO | P - Purchase | $220.30 | +795 | 2,821,355 | 0% | +$175,142 | ||||||
2026-10-08 | HEI | Heico Corp | Culligan Thomas M | Dir | P - Purchase | $220.30 | +795 | 18,518 | +4% | +$175,142 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |